Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, BIO KEY INTERNATIONAL INC reported revenue of $6M, down 14.3% year over year. Operating margin was -115.0% and net margin -120.6%, on a free-cash-flow margin of -78.8% with capital expenditure at 0.2% of revenue. Every figure is computed directly from BKYI's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $6M | -115.0% | -120.6% |
| FY2024 | $7M | -57.9% | -62.1% |
| FY2023 | $8M | -113.8% | -109.9% |
| FY2022 | $7M | -141.4% | -169.7% |
| FY2021 | $5M | -96.6% | -99.0% |
How does BKYI compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: ABM · ACIW · ACN · ACVA · ADBE · ADMQ
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.